Crossmark

Disease burden and costs for patients with hip and knee osteoarthritis and chronic moderate-to-severe refractory pain on treatment with strong opioids in Spain

Crossref DOI link: https://doi.org/10.1016/j.reuma.2022.02.004

Published Print: 2023-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Sicras-Mainar, Antoni

Rejas-Gutierrez, Javier

Vargas-Negrín, Francisco

Tornero-Tornero, Juan Carlos

Sicras-Navarro, Aram

Lizarraga, Isabel
Funding

Funding for this research was provided by:

Sveriges Lantbruksuniversitet

Pfizer

Pfizer Ltd
License Information

Text and Data Mining valid from 2023-02-01
More Information

This article is maintained by: Elsevier

Article Title: Disease burden and costs for patients with hip and knee osteoarthritis and chronic moderate-to-severe refractory pain on treatment with strong opioids in Spain

Journal Title: Reumatología Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reuma.2022.02.004

Content Type: article

Copyright: © 2022 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.

Document is current

Any future updates will be listed below